<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:wfw="http://wellformedweb.org/CommentAPI/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:mayoclinic="http://mayoclinic.org">

<channel>
	<title>Research - Mayo Clinic News Network</title>
	<atom:link href="https://newsnetwork.mayoclinic.org/category/research/feed/" rel="self" type="application/rss+xml">
	<link>https://newsnetwork.mayoclinic.org/category/research/
	<description>News Resources</description>
	<lastbuilddate>Fri, 21 Nov 2025 15:35:29 +0000</lastbuilddate>
	<language>en-US</language>
	<sy:updateperiod>
	hourly	</sy:updateperiod>
	<sy:updatefrequency>
	1	</sy:updatefrequency>
	<generator>https://wordpress.org/?v=6.8.3</generator>
	<item>
		<title>Landmark Mayo Clinic study finds stenting reduces stroke risk in people with carotid artery narrowing</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/landmark-mayo-clinic-study-finds-stenting-reduces-stroke-risk-in-people-with-carotid-artery-narrowing/
		
		<dc:creator><!--[CDATA[Lynda De Widt]]--></dc:creator>
		<pubdate>Fri, 21 Nov 2025 15:33:00 +0000</pubdate>
				<category><!--[CDATA[Clinical Trials]]--></category>
		<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[Florida]]--></category>
		<category><!--[CDATA[News Releases]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[carotid artery stenting]]--></category>
		<category><!--[CDATA[carotid endarterectomy]]--></category>
		<category><!--[CDATA[CREST-2]]--></category>
		<category><!--[CDATA[daily]]--></category>
		<category><!--[CDATA[Dr. Thomas Brott]]--></category>
		<category><!--[CDATA[Florida News Releases]]--></category>
		<category><!--[CDATA[Stroke]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=408062</guid>

					<description><!--[CDATA[<p-->JACKSONVILLE, Fla. — A major international study led by Mayo Clinic researchers and funded by the National Institutes of Health found that for people with severe carotid artery narrowing who haven't experienced recent stroke symptoms, a minimally invasive procedure called carotid artery stenting, combined with intensive medical therapy, significantly lowered stroke risk compared with medical […]<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/landmark-mayo-clinic-study-finds-stenting-reduces-stroke-risk-in-people-with-carotid-artery-narrowing/">Landmark Mayo Clinic study finds stenting reduces stroke risk in people with carotid artery narrowing</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[<div class="wp-block-image is-style-center-align-caption"-->
<figure class="aligncenter size-full is-resized"><img fetchpriority="high" decoding="async" width="912" height="513" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Carotid-artery-angioplasty-and-stenting-2981244-004-0-1-fotor-20251119154217.jpg" alt="Illustration of carotid artery stenting" class="wp-image-408161" style="width:577px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Carotid-artery-angioplasty-and-stenting-2981244-004-0-1-fotor-20251119154217.jpg 912w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Carotid-artery-angioplasty-and-stenting-2981244-004-0-1-fotor-20251119154217-300x169.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Carotid-artery-angioplasty-and-stenting-2981244-004-0-1-fotor-20251119154217-768x432.jpg 768w" sizes="(max-width: 912px) 100vw, 912px"><figcaption class="wp-element-caption">Illustration of carotid artery stenting</figcaption></figure>


<p>JACKSONVILLE, Fla. — A major international study led by <a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> researchers and funded by the National Institutes of Health found that for people with severe <a href="https://www.mayoclinic.org/diseases-conditions/carotid-artery-disease/symptoms-causes/syc-20360519" target="_blank" rel="noreferrer noopener">carotid artery</a> narrowing who haven't experienced recent <a href="https://www.mayoclinic.org/diseases-conditions/stroke/symptoms-causes/syc-20350113" target="_blank" rel="noreferrer noopener">stroke</a> symptoms, a minimally invasive procedure called <a href="https://www.mayoclinic.org/tests-procedures/carotid-angioplasty-and-stenting/about/pac-20385111" target="_blank" rel="noreferrer noopener">carotid artery stenting</a>, combined with intensive medical therapy, significantly lowered stroke risk compared with medical therapy alone. Traditional surgery (<a href="https://www.mayoclinic.org/tests-procedures/carotid-endarterectomy/about/pac-20393379" target="_blank" rel="noreferrer noopener">carotid endarterectomy</a>) did not show the same benefit. The research is <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2508800" target="_blank" rel="noreferrer noopener">published in The New England Journal of Medicine</a>.</p>



<p>The Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) is the largest study to date comparing current treatment approaches for this condition, caused by plaque buildup in the arteries supplying blood to the brain.</p>



<p>Carotid stenosis can lead to a stroke if plaque breaks off and blocks blood flow. Although surgery and stenting have long been used to open these arteries, newer medications and better risk factor control have raised questions about whether these procedures are still needed for people who don't have symptoms.</p>


<div class="wp-block-image">
<figure class="alignright size-full is-resized"><img decoding="async" width="713" height="713" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Thomas-Brott-M.D.-WF7381889-1-x-1.jpg" alt="Thomas Brott, M.D." class="wp-image-408072" style="width:189px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Thomas-Brott-M.D.-WF7381889-1-x-1.jpg 713w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Thomas-Brott-M.D.-WF7381889-1-x-1-300x300.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Thomas-Brott-M.D.-WF7381889-1-x-1-150x150.jpg 150w" sizes="(max-width: 713px) 100vw, 713px"><figcaption class="wp-element-caption">Thomas Brott, M.D.</figcaption></figure></div>


<p>"Decades ago, surgery clearly helped prevent strokes in many patients," says <a href="https://www.mayo.edu/research/faculty/brott-thomas-g-m-d/bio-00027611" target="_blank" rel="noreferrer noopener">Thomas Brott, M.D.</a>, a neurologist at <a href="https://www.mayoclinic.org/patient-visitor-guide/florida" target="_blank" rel="noreferrer noopener">Mayo Clinic in Florida</a> and the study's senior author. "But medical therapy has improved so much that we needed to reexamine the balance between benefit and risk for people who have no symptoms." </p>



<p>The CREST-2 program consisted of two parallel, randomized clinical trials conducted at 155 medical centers in five countries, including Australia, Canada, Israel, Spain and the U.S. Each enrolled more than 1,200 adults with severe carotid artery narrowing of 70% or greater who had not had a stroke or <a href="https://www.mayoclinic.org/diseases-conditions/transient-ischemic-attack/symptoms-causes/syc-20355679" target="_blank" rel="noreferrer noopener">transient ischemic attack</a> (ministroke) in the past six months.</p>



<p>In one trial, participants received stenting plus intensive medical therapy or medical therapy alone. In the other, participants received endarterectomy plus medical therapy or medical therapy alone. </p>



<p>All participants received comprehensive medical care, including lifestyle coaching and medication as needed, to manage their blood pressure, low-density lipoprotein (LDL) <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-q-and-a-cholesterol-know-your-numbers/" target="_blank" rel="noreferrer noopener">cholesterol</a> and <a href="https://www.mayoclinic.org/diseases-conditions/diabetes/symptoms-causes/syc-20371444" target="_blank" rel="noreferrer noopener">diabetes</a>, and to help them stop smoking.</p>



<p>Working with investigators from the University of Alabama at Birmingham, researchers analyzed the occurrence of stroke and death within 44 days of stenting or surgery. They also analyzed the occurrence of stroke over four years on the same side of the body as the narrowed artery.</p>



<p>The stenting trial found a significant reduction in stroke: over four years, 2.8% of patients treated with stenting and medical therapy had a stroke compared to 6% of those on medical therapy alone (roughly half the risk of stroke). However, in the endarterectomy trial, the difference in stroke rates (3.7% with surgery vs. 5.3% with medical therapy alone) was not statistically significant. Serious complications were uncommon with either procedure. &nbsp;</p>



<p>The findings provide clearer guidance for physicians and patients considering a preventive procedure. Dr. Brott emphasizes personalized decision-making.</p>



<p>"For some patients — particularly those with more advanced narrowing or plaque that appears unstable or more likely to cause a blockage — stenting may offer added protection, while for others, medical therapy alone may be enough," he says.</p>



<p>Close follow-up and coordinated care helped all participants achieve and maintain significant improvements in their blood pressure and cholesterol levels.</p>



<p>Researchers will continue to track participants for long-term results. They are also studying whether imaging tools can help identify which patients benefit most from each treatment.</p>



<p>For a full list of authors and disclosures, see the <a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2508800" target="_blank" rel="noreferrer noopener">paper</a>.</p>



<p><strong>Related:</strong> <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-neurologists-lead-international-study-to-test-best-approach-to-stroke-prevention/" target="_blank" rel="noreferrer noopener">Mayo Clinic Neurologists Lead International Study to Test Best Approach to Stroke Prevention</a></p>



<p>###</p>



<p><strong>About Mayo Clinic</strong> <br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the&nbsp;<a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a>&nbsp;for additional Mayo Clinic news.&nbsp;</p>



<p><strong>Media contact:</strong></p>



<ul class="wp-block-list">
<li>Julie Ferris-Tillman, Ph.D., Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/landmark-mayo-clinic-study-finds-stenting-reduces-stroke-risk-in-people-with-carotid-artery-narrowing/">Landmark Mayo Clinic study finds stenting reduces stroke risk in people with carotid artery narrowing</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Carotid-artery-illustration-shutterstock_130089680-1-x-1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Carotid-artery-angioplasty-and-stenting-2981244-004-0-1-fotor-20251119154217.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[carotid artery stenting]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[carotid endarterectomy]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[CREST-2]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[daily]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Thomas Brott]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Florida News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Stroke]]--></mayoclinic:mctag>	</item>
		<item>
		<title>Mayo Clinic physicians map patients’ brain waves to personalize epilepsy treatment</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-physicians-map-patients-brain-waves-to-personalize-epilepsy-treatment/
		
		<dc:creator><!--[CDATA[Alison Satake]]--></dc:creator>
		<pubdate>Thu, 20 Nov 2025 14:05:00 +0000</pubdate>
				<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[Individualized Medicine]]--></category>
		<category><!--[CDATA[Minnesota]]--></category>
		<category><!--[CDATA[Neurosciences]]--></category>
		<category><!--[CDATA[News Releases]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[daily]]--></category>
		<category><!--[CDATA[Dr. Nick Gregg]]--></category>
		<category><!--[CDATA[Minnesota News Releases]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=407964</guid>

					<description><!--[CDATA[<p-->Neurologist Nick Gregg, M.D., and team developed a personalized approach to deep brain stimulation (DBS) that maps each patient's seizure network before epilepsy treatment.<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-physicians-map-patients-brain-waves-to-personalize-epilepsy-treatment/">Mayo Clinic physicians map patients’ brain waves to personalize epilepsy treatment</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[
<figure class="wp-block-image size-large"--><img decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Gregg-brain-scan16.x9-1024x576.jpg" alt="" class="wp-image-407976" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Gregg-brain-scan16.x9-1024x576.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Gregg-brain-scan16.x9-300x169.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Gregg-brain-scan16.x9-768x432.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Gregg-brain-scan16.x9-1536x864.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Gregg-brain-scan16.x9.jpg 1920w" sizes="(max-width: 1024px) 100vw, 1024px">



<p>ROCHESTER, Minn. — <a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> researchers have developed a new, personalized approach to <a href="https://www.mayoclinic.org/tests-procedures/deep-brain-stimulation/about/pac-20384562" target="_blank" rel="noreferrer noopener">deep brain stimulation (DBS)</a> for people with drug-resistant <a href="https://www.mayoclinic.org/diseases-conditions/epilepsy/symptoms-causes/syc-20350093" target="_blank" rel="noreferrer noopener">epilepsy</a>. By mapping each patient's unique brain wave patterns, the method allows physicians to target the precise area in the brain where stimulation is most effective, moving beyond the traditional one-size-fits-all approach.</p>



<p>DBS involves implanting electrodes in the brain to deliver electrical pulses that help prevent and control <a href="https://www.mayoclinic.org/diseases-conditions/seizure/symptoms-causes/syc-20365711" target="_blank" rel="noreferrer noopener">seizures</a>. While effective, DBS is typically administered with electrodes placed in the same brain region across most patients. Mayo Clinic physician-scientists are now tailoring the treatment to an individual's seizure network before DBS placement.</p>



<p>"Our unique approach aims to tailor neuromodulation for each patient," says <a href="https://www.mayo.edu/research/faculty/gregg-nick-m-m-d/bio-20544978" target="_blank" rel="noreferrer noopener">Nick Gregg, M.D.</a>, a Mayo Clinic <a href="https://www.mayoclinic.org/biographies/gregg-nick-m-m-d/bio-20544357" target="_blank" rel="noreferrer noopener">neurologist</a> and lead author of a paper published in the <a href="https://onlinelibrary.wiley.com/doi/10.1002/ana.78087" target="_blank" rel="noreferrer noopener">Annals of Neurology</a>. "We're moving away from one-size-fits-all to an individualized approach that maximizes seizure network engagement to better modulate abnormal brain wave activity."</p>



<p>Once researchers identify the specific area in the thalamus — a small relay hub deep within the brain — that connects to a patient's seizure network, they can fine-tune stimulation settings for that individual. Because seizures occur infrequently, clinicians analyze erratic brain wave patterns that signal abnormal activity.<br><br>"We're trying to disrupt the pathological hypersynchrony and reduce network excitability to lower seizure risk," says Dr. Gregg.<br><br>Ten patients received this personalized approach while being evaluated for epilepsy surgery. The next phase of research will follow those who have since received permanent DBS implants using this personalized approach.</p>



<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:50%">
<p><br></p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/N_M_Gregg_0014-1024x683.jpg" alt="Photo of Nick Gregg, M.D." class="wp-image-407972" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/N_M_Gregg_0014-1024x683.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/N_M_Gregg_0014-300x200.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/N_M_Gregg_0014-768x512.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/N_M_Gregg_0014-1536x1024.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/N_M_Gregg_0014-2048x1365.jpg 2048w" sizes="auto, (max-width: 1024px) 100vw, 1024px"><figcaption class="wp-element-caption">Nick Gregg, M.D.</figcaption></figure>
</div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow" style="flex-basis:50%">
<figure class="wp-block-pullquote" style="min-height:0px;margin-top:var(--wp--preset--spacing--60);margin-right:0;margin-bottom:var(--wp--preset--spacing--60);margin-left:0;padding-top:var(--wp--preset--spacing--20);padding-right:0;padding-bottom:var(--wp--preset--spacing--20);padding-left:0;font-size:25px"><blockquote><p>"The long-term goal is to quiet the seizure network, so it is eventually forgotten. Reorganizing the neuronal network could move us beyond controlling seizures to actually curing epilepsy."</p></blockquote></figure>
</div>
</div>



<p><br>This research is part of Mayo Clinic's<strong> </strong>Bioelectronic Neuromodulation Innovation to Cure (BIONIC) initiative, which unites clinical insight with cutting-edge engineering to deliver novel diagnostics and therapies. Through intellectual property development, strategic partnerships and patient-centered trials, BIONIC transforms innovation into impact — advancing care for complex neurological conditions.<br><br>Dr. Gregg's research was supported by the Tianqiao &amp; Chrissy Chen Institute. Review the <a href="https://onlinelibrary.wiley.com/doi/10.1002/ana.78087" target="_blank" rel="noreferrer noopener">study</a> for a complete list of authors, disclosures and funding.<a id="_msocom_1"></a></p>



<p>###</p>



<p><strong>About Mayo Clinic</strong><br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the <a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a> for additional Mayo Clinic news.</p>



<p><strong>Media contact:</strong></p>



<ul class="wp-block-list">
<li>Tia Ford, Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-physicians-map-patients-brain-waves-to-personalize-epilepsy-treatment/">Mayo Clinic physicians map patients’ brain waves to personalize epilepsy treatment</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Gregg-brain-scan1.x1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Gregg-brain-scan16.x9.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[daily]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Nick Gregg]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Minnesota News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[News Releases]]--></mayoclinic:mctag>	</item>
		<item>
		<title>Most people with a genetic condition that causes significantly high cholesterol go undiagnosed, Mayo Clinic study finds&nbsp;&nbsp;</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/most-people-with-a-genetic-condition-that-causes-significantly-high-cholesterol-go-undiagnosed-mayo-clinic-study-finds/
		
		<dc:creator><!--[CDATA[Susan Murphy]]--></dc:creator>
		<pubdate>Tue, 18 Nov 2025 15:15:58 +0000</pubdate>
				<category><!--[CDATA[Arizona]]--></category>
		<category><!--[CDATA[Cardiovascular]]--></category>
		<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[Individualized Medicine]]--></category>
		<category><!--[CDATA[News Releases]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[Arizona News Releases]]--></category>
		<category><!--[CDATA[daily]]--></category>
		<category><!--[CDATA[Dr. Jewel Samadder]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=407967</guid>

					<description><!--[CDATA[<p-->PHOENIX — Current genetic screening guidelines fail to identify most people with an inherited condition known as familial hypercholesterolemia that can cause dangerously high cholesterol and early heart disease, a Mayo Clinic study found.&nbsp; The condition often passes silently through families for generations. It is highly treatable, yet people who remain undiagnosed are at greater […]<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/most-people-with-a-genetic-condition-that-causes-significantly-high-cholesterol-go-undiagnosed-mayo-clinic-study-finds/">Most people with a genetic condition that causes significantly high cholesterol go undiagnosed, Mayo Clinic study finds&nbsp;&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[
<figure class="wp-block-image size-large"--><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-heart-dna-1024x576.png" alt="" class="wp-image-407981" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-heart-dna-1024x576.png 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-heart-dna-300x169.png 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-heart-dna-768x432.png 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-heart-dna-1536x864.png 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-heart-dna.png 1920w" sizes="auto, (max-width: 1024px) 100vw, 1024px">



<p>PHOENIX — Current genetic screening guidelines fail to identify most people with an inherited condition known as <a href="https://www.mayoclinic.org/diseases-conditions/familial-hypercholesterolemia/symptoms-causes/syc-20353755" target="_blank" rel="noreferrer noopener">familial hypercholesterolemia</a> that can cause dangerously <a href="https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/symptoms-causes/syc-20350800" target="_blank" rel="noreferrer noopener">high cholesterol</a> and early heart disease, a Mayo Clinic study found.&nbsp;</p>



<p>The condition often passes silently through families for generations. It is highly treatable, yet people who remain undiagnosed are at greater risk for heart attacks and strokes.&nbsp;</p>



<p>Cardiovascular disease remains the leading cause of death in the United States, affecting millions of adults each year. It includes conditions such as coronary artery disease, heart failure and stroke. One of its key risk factors is high cholesterol.&nbsp;</p>



<p>The study, <a href="https://www.ahajournals.org/doi/10.1161/CIRCGEN.125.005174" target="_blank" rel="noreferrer noopener">published</a> in Circulation: Genomic and Precision Medicine, suggests that routine screening could identify the majority of people with the inherited condition and, ultimately, save lives.&nbsp;</p>



<h2 class="wp-block-heading"><strong>Study reveals missed diagnoses</strong>&nbsp;</h2>



<p>Researchers found that nearly 90% of those with familial hypercholesterolemia would not have been flagged for standard genetic testing and were unaware they had the condition until DNA testing in a Mayo Clinic population-based research study identified them. About 1 in 5 had already developed coronary artery disease.&nbsp;</p>



<p>"Our findings expose a blind spot in current national guidelines, which rely on cholesterol levels and family history to determine who should receive genetic testing," says <a href="https://www.mayo.edu/research/faculty/samadder-niloy-jewel-m-d/bio-20396993" target="_blank" rel="noreferrer noopener">Niloy Jewel Samadder, M.D.</a>, lead author and a Mayo Clinic gastroenterologist and cancer geneticist at the <a href="https://www.mayoclinic.org/departments-centers/mayo-clinic-cancer-center" target="_blank" rel="noreferrer noopener">Mayo Clinic Comprehensive Cancer Center</a>. "If we can find those at risk of cardiovascular disease early, we can treat it early and change its course and likely save lives."&nbsp;</p>



<p>Familial hypercholesterolemia is one of the most common genetic conditions, affecting an estimated 1 in 200 to 250 people worldwide. It causes very high levels of low-density lipoprotein (LDL) cholesterol — the "bad" cholesterol — from birth.&nbsp;&nbsp;</p>



<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><div class="wp-block-image">
<figure class="aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="819" height="1024" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Samadder-Jewel-J._14157926_20240205-819x1024.jpg" alt="" class="wp-image-407984" style="width:306px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Samadder-Jewel-J._14157926_20240205-819x1024.jpg 819w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Samadder-Jewel-J._14157926_20240205-240x300.jpg 240w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Samadder-Jewel-J._14157926_20240205-768x960.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Samadder-Jewel-J._14157926_20240205-1229x1536.jpg 1229w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Samadder-Jewel-J._14157926_20240205-1638x2048.jpg 1638w" sizes="auto, (max-width: 819px) 100vw, 819px"><figcaption class="wp-element-caption">Niloy Jewel Samadder, M.D</figcaption></figure></div></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow">
<figure class="wp-block-pullquote" style="padding-top:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--20)"><blockquote><p>"Our findings expose a blind spot in current national guidelines, which rely on cholesterol levels and family history to determine who should receive genetic testing. If we can find those at risk of cardiovascular disease early, we can treat it early and change its course and likely save lives."&nbsp;</p></blockquote></figure>
</div>
</div>



<div style="height:20px" aria-hidden="true" class="wp-block-spacer"></div>



<p>The study analyzed data from exome sequencing, a form of genetic testing that reads the protein-coding regions of the genome — where most disease-causing variants are found. The research included more than 84,000 participants across Mayo Clinic sites in Arizona, Florida and Minnesota through the <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinics-largest-ever-exome-study-offers-blueprint-for-biomedical-breakthroughs/" target="_blank" rel="noreferrer noopener">Tapestry DNA research study</a>, part of the institution's effort to integrate genomics into everyday patient care.&nbsp;&nbsp;</p>



<p>The research team identified 419 people with genetic variants known to cause familial hypercholesterolemia. They found that nearly 75% of those individuals would not have met current clinical criteria for genetic testing based on their cholesterol levels or family history. This represents a missed opportunity for disease prevention.&nbsp;&nbsp;</p>



<h2 class="wp-block-heading"><strong>Integrating genetics into preventive care</strong>&nbsp;</h2>



<p>Dr. Samadder says the next step is to bring genetic screening into routine care to identify high-risk patients earlier and start treatment sooner.&nbsp;</p>



<p>The work is part of Mayo Clinic's Precure strategic priority, which aims to predict and prevent serious diseases before they advance. Through innovative technologies and population-based studies, Precure is designed to bring prevention-focused care directly to patients sooner.&nbsp;&nbsp;</p>



<p>For a complete list of authors, disclosures and funding, review the <a href="https://www.ahajournals.org/doi/10.1161/CIRCGEN.125.005174" target="_blank" rel="noreferrer noopener">study</a>.&nbsp;&nbsp;&nbsp;&nbsp;</p>



<p>###&nbsp;&nbsp;</p>



<p><strong>About Mayo Clinic&nbsp;</strong>&nbsp;<br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the <a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a> for additional Mayo Clinic news.&nbsp;&nbsp;</p>



<p><strong>Media contact</strong>:</p>



<ul class="wp-block-list">
<li>Terri Malloy, Mayo Clinic Communications,&nbsp;<a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>



<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/most-people-with-a-genetic-condition-that-causes-significantly-high-cholesterol-go-undiagnosed-mayo-clinic-study-finds/">Most people with a genetic condition that causes significantly high cholesterol go undiagnosed, Mayo Clinic study finds&nbsp;&nbsp;</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/1x1-heart-dna.png</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-heart-dna.png</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Arizona News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[daily]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Jewel Samadder]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[News Releases]]--></mayoclinic:mctag>	</item>
		<item>
		<title>Mayo Clinic scientists create tool to predict Alzheimer’s risk years before symptoms begin</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-scientists-create-tool-to-predict-alzheimers-risk-years-before-symptoms-begin/
		
		<dc:creator><!--[CDATA[Alison Satake]]--></dc:creator>
		<pubdate>Wed, 12 Nov 2025 23:31:51 +0000</pubdate>
				<category><!--[CDATA[Aging]]--></category>
		<category><!--[CDATA[Discovery Science]]--></category>
		<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[Minnesota]]--></category>
		<category><!--[CDATA[Neurosciences]]--></category>
		<category><!--[CDATA[News Releases]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[daily]]--></category>
		<category><!--[CDATA[Dr. Clifford Jack Jr]]--></category>
		<category><!--[CDATA[Dr. Ronald Petersen]]--></category>
		<category><!--[CDATA[Dr. Terry Therneau]]--></category>
		<category><!--[CDATA[Minnesota News Releases]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=407728</guid>

					<description><!--[CDATA[<p-->Researchers have developed a new tool that can estimate a person's risk of developing memory and thinking problems associated with Alzheimer's disease years before symptoms appear. <p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-scientists-create-tool-to-predict-alzheimers-risk-years-before-symptoms-begin/">Mayo Clinic scientists create tool to predict Alzheimer’s risk years before symptoms begin</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[
<figure class="wp-block-image size-large"--><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/GettyImages-1699021178-16x9-1-1024x576.jpg" alt="Photo of woman in city area." class="wp-image-407759" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/GettyImages-1699021178-16x9-1-1024x576.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/GettyImages-1699021178-16x9-1-300x169.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/GettyImages-1699021178-16x9-1-768x432.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/GettyImages-1699021178-16x9-1-1536x864.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/GettyImages-1699021178-16x9-1.jpg 1920w" sizes="auto, (max-width: 1024px) 100vw, 1024px"><figcaption class="wp-element-caption">Getty Images</figcaption>



<p>ROCHESTER, Minn. — Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking problems associated with <a href="https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447" target="_blank" rel="noreferrer noopener">Alzheimer's disease</a> years before symptoms appear. The research, published in <a href="https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00350-3/fulltext" target="_blank" rel="noreferrer noopener">The Lancet Neurology</a>, builds on decades of data from the <a href="https://www.mayo.edu/research/centers-programs/alzheimers-disease-research-center/research-activities/mayo-clinic-study-aging/overview" target="_blank" rel="noreferrer noopener">Mayo Clinic Study of Aging</a> — one of the world's most comprehensive population-based studies of brain health.</p>



<p>The study found that women have a higher lifetime risk than men of developing dementia and <a href="https://www.mayoclinic.org/diseases-conditions/mild-cognitive-impairment/symptoms-causes/syc-20354578" target="_blank" rel="noreferrer noopener">mild cognitive impairment (MCI)</a>, a transitional stage between healthy aging and dementia that often affects quality of life but still allows people to live independently. Men and women with the common genetic variant, APOE ε4, also have higher lifetime risk.</p>



<h2 class="wp-block-heading"><strong>Predicting Alzheimer's disease</strong></h2>



<p>Alzheimer's disease is marked by two key proteins in the brain: amyloid, which forms plaques, and tau, which forms tangles. Drugs recently approved by the Food and Drug Administration remove amyloid from the brain and can slow the rate of disease progression for people with MCI or mild dementia.</p>


<div class="wp-block-image">
<figure class="alignright size-large is-resized"><img loading="lazy" decoding="async" width="776" height="1024" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Clifford-Jack-WF5115610_0012-776x1024.jpg" alt="Photo of Dr. Clifford Jack, Jr." class="wp-image-407731" style="width:239px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Clifford-Jack-WF5115610_0012-776x1024.jpg 776w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Clifford-Jack-WF5115610_0012-227x300.jpg 227w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Clifford-Jack-WF5115610_0012-768x1014.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Clifford-Jack-WF5115610_0012-1163x1536.jpg 1163w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Clifford-Jack-WF5115610_0012-1551x2048.jpg 1551w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Clifford-Jack-WF5115610_0012.jpg 1910w" sizes="auto, (max-width: 776px) 100vw, 776px"><figcaption class="wp-element-caption">Clifford Jack, Jr., M.D.</figcaption></figure></div>


<p>"What's exciting now is that we're looking even earlier — before symptoms begin — to see if we can predict who might be at greatest risk of developing cognitive problems in the future," says <a href="https://www.mayo.edu/research/faculty/jack-clifford-r-jr-m-d/bio-00026247" target="_blank" rel="noreferrer noopener">Clifford Jack, Jr., M.D.</a>, radiologist and lead author of the study.</p>



<p>The new prediction model combined several factors, including age, sex, genetic risk as associated with APOE genotype and brain amyloid levels detected on <a href="https://www.mayoclinic.org/tests-procedures/pet-scan/about/pac-20385078" target="_blank" rel="noreferrer noopener">PET scans</a>. Using the data, researchers can calculate an individual's likelihood of developing MCI or dementia within 10 years or over the predicted lifetime. Of all the predictors evaluated, the brain amyloid levels detected on PET scans was the predictor with the largest effect for lifetime risk of both MCI and dementia.</p>


<div class="wp-block-image">
<figure class="alignright size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="683" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/1418006_3625687_0006-1024x683.jpg" alt="Photo of Dr. Ronald Petersen" class="wp-image-407733" style="width:334px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/1418006_3625687_0006-1024x683.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/1418006_3625687_0006-300x200.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/1418006_3625687_0006-768x512.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/1418006_3625687_0006-1536x1024.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/1418006_3625687_0006-2048x1365.jpg 2048w" sizes="auto, (max-width: 1024px) 100vw, 1024px"><figcaption class="wp-element-caption">Ronald Petersen, M.D., Ph.D.</figcaption></figure></div>


<p>"This kind of risk estimate could eventually help people and their doctors decide when to begin therapy or make lifestyle changes that may delay the onset of symptoms. It's similar to how cholesterol levels help predict heart attack risk," says <a href="https://www.mayo.edu/research/faculty/petersen-ronald-c-m-d-ph-d/bio-00078363" target="_blank" rel="noreferrer noopener">Ronald Petersen, M.D., Ph.D.</a>, neurologist and director of the Mayo Clinic Study of Aging, who is a co-author of the study.</p>



<p>The research stands apart because it draws from the Mayo Clinic Study of Aging, a long-running effort in Olmsted County, Minnesota, that tracks thousands of residents over time. The analysis for this study included data from 5,858 participants. Unlike most studies, Mayo researchers are able to continue following participants even after they stop actively taking part, using medical record data — ensuring nearly complete information about who develops cognitive decline or dementia.</p>


<div class="wp-block-image">
<figure class="alignright size-large is-resized"><img loading="lazy" decoding="async" width="819" height="1024" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Therneau-Terry-M._10167951_202505071328-819x1024.jpg" alt="Photo of Dr. Terry Therneau" class="wp-image-407734" style="width:240px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Therneau-Terry-M._10167951_202505071328-819x1024.jpg 819w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Therneau-Terry-M._10167951_202505071328-240x300.jpg 240w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Therneau-Terry-M._10167951_202505071328-768x960.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Therneau-Terry-M._10167951_202505071328-1229x1536.jpg 1229w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Therneau-Terry-M._10167951_202505071328-1639x2048.jpg 1639w" sizes="auto, (max-width: 819px) 100vw, 819px"><figcaption class="wp-element-caption">Terry Therneau, Ph.D.</figcaption></figure></div>


<p>"This gives us a uniquely accurate picture of how Alzheimer's unfolds in the community," says <a href="https://www.mayo.edu/research/faculty/therneau-terry-m-ph-d/bio-00025991" target="_blank" rel="noreferrer noopener">Terry Therneau, Ph.D.</a>, who led the statistical analysis and is the senior author of the study. "We found that the incident rate of dementia was two times greater among the people who dropped out of the study than those who continued to participate."</p>



<p>The study elevates the significance of MCI, which is the stage targeted by current Alzheimer's drugs that slow but do not stop progression.</p>



<p>While the new tool is currently a research instrument, it represents a major step toward more personalized care. Future versions may incorporate blood-based biomarkers, which could make testing more accessible.</p>



<p>The work was supported by the National Institute on Aging, the GHR Foundation, Gates Ventures and the Alexander Family Foundation.</p>



<p>The research is part of a larger effort at Mayo Clinic called the Precure initiative focused on developing tools that empower clinicians to predict and intercept biological processes before they evolve into disease or progress into complex, hard-to-treat conditions.</p>



<p>"Ultimately, our goal is to give people more time — time to plan, to act and to live well before memory problems take hold," says Dr. Petersen.</p>



<p>Review the <a href="https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(25)00350-3/fulltext" target="_blank" rel="noreferrer noopener">study</a> for a complete list of authors, disclosures and funding.</p>



<p>###&nbsp;</p>



<p><strong>About Mayo Clinic&nbsp;<br></strong><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the <a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a> for additional Mayo Clinic news.&nbsp;</p>



<p><strong>Media contact:</strong></p>



<ul class="wp-block-list">
<li>Tia Ford, Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-scientists-create-tool-to-predict-alzheimers-risk-years-before-symptoms-begin/">Mayo Clinic scientists create tool to predict Alzheimer’s risk years before symptoms begin</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/GettyImages-1699021178-1x1-1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/GettyImages-1699021178-16x9-1.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[daily]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Clifford Jack Jr]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Ronald Petersen]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Terry Therneau]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Minnesota News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[News Releases]]--></mayoclinic:mctag>	</item>
		<item>
		<title>Mayo Clinic researchers use AI and genetics to identify early signs of a rare, life-threatening heart condition</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-use-ai-and-genetics-to-identify-early-signs-of-a-rare-life-threatening-heart-condition/
		
		<dc:creator><!--[CDATA[Susan Murphy]]--></dc:creator>
		<pubdate>Mon, 10 Nov 2025 11:00:00 +0000</pubdate>
				<category><!--[CDATA[AI and Digital Health]]--></category>
		<category><!--[CDATA[Cardiovascular]]--></category>
		<category><!--[CDATA[Discovery Science]]--></category>
		<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[Individualized Medicine]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[Translational Science]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[daily]]--></category>
		<category><!--[CDATA[Dr. Ammar Killu]]--></category>
		<category><!--[CDATA[Dr. John Giudicessi]]--></category>
		<category><!--[CDATA[Dr. Peter Noseworthy]]--></category>
		<category><!--[CDATA[Mayo Clinic]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=407545</guid>

					<description><!--[CDATA[<p-->ROCHESTER, Minn. —&nbsp;At&nbsp;Mayo Clinic, cardiologists&nbsp;Peter Noseworthy, M.D., and&nbsp;John Giudicessi, M.D., Ph.D., are uncovering the earliest signs of a genetic heart condition that often strikes without warning. Their work shows that&nbsp;early detection, and even&nbsp;prevention,&nbsp;may be possible long before symptoms appear.&nbsp; The condition,&nbsp;arrhythmogenic right ventricular cardiomyopathy, weakens the&nbsp;molecules&nbsp;that hold heart cells together. As those bonds deteriorate, healthy&nbsp;muscle […]<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-use-ai-and-genetics-to-identify-early-signs-of-a-rare-life-threatening-heart-condition/">Mayo Clinic researchers use AI and genetics to identify early signs of a rare, life-threatening heart condition</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[
<figure class="wp-block-image size-large"--><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-cardiology77-1024x576.png" alt="" class="wp-image-407726" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-cardiology77-1024x576.png 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-cardiology77-300x169.png 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-cardiology77-768x432.png 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-cardiology77-1536x864.png 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-cardiology77.png 1920w" sizes="auto, (max-width: 1024px) 100vw, 1024px">



<p>ROCHESTER, Minn. —&nbsp;At&nbsp;<a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>, cardiologists&nbsp;<a href="https://www.mayo.edu/research/faculty/noseworthy-peter-a-m-d-m-b-a/bio-20094212" target="_blank" rel="noreferrer noopener">Peter Noseworthy, M.D.</a>, and&nbsp;<a href="https://www.mayoclinic.org/biographies/giudicessi-john-r-m-d-ph-d/bio-20532305" target="_blank" rel="noreferrer noopener">John Giudicessi, M.D., Ph.D.</a>, are uncovering the earliest signs of a genetic heart condition that often strikes without warning. Their work shows that&nbsp;early detection, and even&nbsp;prevention,&nbsp;may be possible long before symptoms appear.&nbsp;</p>



<p>The condition,&nbsp;<a href="https://www.mayoclinic.org/diseases-conditions/cardiomyopathy/symptoms-causes/syc-20370709" target="_blank" rel="noreferrer noopener">arrhythmogenic right ventricular cardiomyopathy</a>, weakens the&nbsp;molecules&nbsp;that hold heart cells together. As those bonds deteriorate, healthy&nbsp;muscle is&nbsp;replaced with scar&nbsp;tissue&nbsp;and fat,&nbsp;leaving the heart weaker.&nbsp;&nbsp;</p>



<p>The disease often advances silently. Sometimes the first sign is&nbsp;when a person&nbsp;suddenly&nbsp;collapses&nbsp;during exercise. For many,&nbsp;a&nbsp;diagnosis comes only after the heart is already damaged. Detecting it earlier could spare patients from heart failure,&nbsp;the need for a&nbsp;transplant or sudden death.&nbsp;</p>



<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><div class="wp-block-image">
<figure class="aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="819" height="1024" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Noseworthy-Peter-A._14421810_20240205-2-819x1024.jpg" alt="" class="wp-image-407619" style="width:301px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Noseworthy-Peter-A._14421810_20240205-2-819x1024.jpg 819w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Noseworthy-Peter-A._14421810_20240205-2-240x300.jpg 240w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Noseworthy-Peter-A._14421810_20240205-2-768x960.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Noseworthy-Peter-A._14421810_20240205-2-1229x1536.jpg 1229w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Noseworthy-Peter-A._14421810_20240205-2-1638x2048.jpg 1638w" sizes="auto, (max-width: 819px) 100vw, 819px"><figcaption class="wp-element-caption">Dr. Peter Noseworthy</figcaption></figure></div></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow">
<figure class="wp-block-pullquote alignleft has-medium-font-size" style="padding-top:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--20)"><blockquote><p>"We spend so much time managing the consequences of this disease — ablations, transplants, repeated hospitalizations. It's a much better paradigm to ask:&nbsp;What can we do to prevent this in the first place?"&nbsp;</p></blockquote></figure>
</div>
</div>



<div style="height:20px" aria-hidden="true" class="wp-block-spacer"></div>



<p>"We spend so much time managing the consequences of this disease — ablations, transplants, repeated hospitalizations,"&nbsp;Dr. Noseworthy&nbsp;says.&nbsp;"It's a much better paradigm to ask:&nbsp;What can we do to prevent this in the first place?"&nbsp;</p>



<h2 class="wp-block-heading"><strong>Leading a new era of heart care</strong>&nbsp;</h2>



<p>Dr. Noseworthy leads Mayo Clinic's Division of Heart Rhythm Services, where he cares for patients with heart rhythm disorders and helps guide innovation strategies&nbsp;across the institution. Much of his research centers on using digital tools and&nbsp;artificial intelligence (AI)&nbsp;to detect problems earlier and improve patient care.&nbsp;</p>



<p>Dr. Giudicessi, a&nbsp;genetic cardiologist, focuses on inherited heart rhythm conditions and how genetic changes influence who develops disease. His work bridges patient care and laboratory research, including&nbsp;first-in-human clinical trials&nbsp;that explore the potential of gene therapy.&nbsp;</p>



<p>Together, they&nbsp;turned to two powerful data sources: the genetic code that shapes the heart and the electrical signals that guide its rhythm.&nbsp;</p>



<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><div class="wp-block-image">
<figure class="aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="853" height="1024" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Giudicessi-John-R._14433664_202107200353-1-853x1024.jpg" alt="" class="wp-image-407616" style="width:328px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Giudicessi-John-R._14433664_202107200353-1-853x1024.jpg 853w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Giudicessi-John-R._14433664_202107200353-1-250x300.jpg 250w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Giudicessi-John-R._14433664_202107200353-1-768x922.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Giudicessi-John-R._14433664_202107200353-1.jpg 1250w" sizes="auto, (max-width: 853px) 100vw, 853px"><figcaption class="wp-element-caption">Dr. John Giudicessi</figcaption></figure></div></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow">
<figure class="wp-block-pullquote alignleft has-medium-font-size" style="padding-top:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--20)"><blockquote><p>"So much of medicine is reactionary&nbsp;— we wait for something bad to happen. This work is ushering in the tools to&nbsp;push&nbsp;against disease&nbsp;and&nbsp;to identify it early."&nbsp;</p></blockquote></figure>
</div>
</div>



<div style="height:20px" aria-hidden="true" class="wp-block-spacer"></div>



<h2 class="wp-block-heading"><strong>Pinpointing risk in genes and rhythm&nbsp;</strong>&nbsp;</h2>



<p>Their search for answers started&nbsp;in&nbsp;Mayo Clinic's new Research Data Atlas,&nbsp;which unites decades of genetic, clinical and biospecimen data.&nbsp;Within it, they&nbsp;identified&nbsp;people carrying&nbsp;disease-causing&nbsp;mutations in&nbsp;PKP2,&nbsp;the gene most often linked to this disease.&nbsp;&nbsp;</p>



<p>About 1 in 2,000 people carry&nbsp;a mutation in the&nbsp;PKP2&nbsp;gene, but many&nbsp;never develop&nbsp;the&nbsp;disease.&nbsp;The challenge is knowing who will — and stepping in early enough to change the outcome. That question drives Dr. Giudicessi's work.&nbsp;</p>



<p>"So much of medicine is reactionary&nbsp;— we wait for something bad to happen,"&nbsp;Dr. Giudicessi says.&nbsp;"This work is ushering in the tools to&nbsp;push&nbsp;against disease&nbsp;and&nbsp;to identify it early."&nbsp;</p>



<p>To spot those early rhythm changes, the team drew on an AI model developed by&nbsp;Mayo Clinic cardiologist&nbsp;<a href="https://www.mayo.edu/research/faculty/killu-ammar-m-m-b-b-s/bio-20537109" target="_blank" rel="noreferrer noopener">Ammar Killu, M.B.B.S.</a>,&nbsp;and his team.&nbsp;&nbsp;</p>



<p>Analyzing&nbsp;electrocardiograms from patients with a PKP2 mutation, the AI helped the researchers&nbsp;identify&nbsp;faint patterns that marked the first signs of disease.&nbsp;&nbsp;</p>



<div class="wp-block-columns is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex">
<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow"><div class="wp-block-image">
<figure class="aligncenter size-large is-resized"><img loading="lazy" decoding="async" width="853" height="1024" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Killu-Ammar-M.-MBBS_15346978_201709080945-853x1024.jpg" alt="" class="wp-image-407617" style="width:315px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Killu-Ammar-M.-MBBS_15346978_201709080945-853x1024.jpg 853w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Killu-Ammar-M.-MBBS_15346978_201709080945-250x300.jpg 250w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Killu-Ammar-M.-MBBS_15346978_201709080945-768x922.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Killu-Ammar-M.-MBBS_15346978_201709080945.jpg 1250w" sizes="auto, (max-width: 853px) 100vw, 853px"><figcaption class="wp-element-caption">Dr. Ammar Killu</figcaption></figure></div></div>



<div class="wp-block-column is-layout-flow wp-block-column-is-layout-flow">
<figure class="wp-block-pullquote" style="padding-top:var(--wp--preset--spacing--20);padding-bottom:var(--wp--preset--spacing--20)"><blockquote><p>"This research shows how&nbsp;AI&nbsp;can help us&nbsp;identify really subtle changes that may facilitate earlier diagnosis and then&nbsp;allow us to&nbsp;move beyond individual cases to understand&nbsp;patterns across populations."</p></blockquote></figure>
</div>
</div>



<div style="height:20px" aria-hidden="true" class="wp-block-spacer"></div>



<p>"This research shows how&nbsp;AI&nbsp;can help us&nbsp;identify really subtle changes that may facilitate earlier diagnosis and then&nbsp;allow us to&nbsp;move beyond individual cases to understand&nbsp;patterns across populations,"&nbsp;Dr.&nbsp;Killu&nbsp;says.&nbsp;"It's a powerful example of how we can scale early detection to reach more patients before disease takes hold."&nbsp;</p>



<p>Those insights led to&nbsp;a next&nbsp;step.&nbsp;Guided by the AI findings,&nbsp;Dr.&nbsp;Noseworthy&nbsp;and Dr.&nbsp;Giudicessi&nbsp;provided smartwatches to people&nbsp;who were&nbsp;showing early signs of disease. The devices help track daily activity levels&nbsp;—&nbsp;important&nbsp;data, since strenuous exercise can accelerate the disease, while even small adjustments may help slow it.&nbsp;</p>



<p>The researchers are also exploring gene therapy for PKP2. Still in early testing, the approach may one day restore the missing gene and keep the disease from advancing.&nbsp;</p>



<h2 class="wp-block-heading"><strong>Building medicine's next chapter</strong>&nbsp;</h2>



<p>Their&nbsp;work is part of&nbsp;a larger shift at Mayo Clinic: predicting and preventing disease before it takes hold. That vision drives Precure, an initiative to intercept serious conditions early enough to alter their course. With tools like the Research Data Atlas, investigators can study health patterns across large populations, detect risk sooner and&nbsp;potentially&nbsp;guide people to care before disease advances.&nbsp;</p>



<p>For Dr. Noseworthy, Dr. Giudicessi and Dr. Killu, the&nbsp;vision&nbsp;is bigger than a single study. They are helping build the infrastructure to move medicine earlier in the course of disease, where illness can be intercepted at scale.&nbsp;</p>



<p>###</p>



<p><strong>About Mayo Clinic</strong><br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the&nbsp;<a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a>&nbsp;for additional Mayo Clinic news.&nbsp;&nbsp;</p>



<p><strong>Media contact</strong>:</p>



<ul class="wp-block-list">
<li>Terri Malloy, Mayo Clinic Communications,&nbsp;<a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-use-ai-and-genetics-to-identify-early-signs-of-a-rare-life-threatening-heart-condition/">Mayo Clinic researchers use AI and genetics to identify early signs of a rare, life-threatening heart condition</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/1x1-cardiology55.png</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/16x9-cardiology77.png</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[daily]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Ammar Killu]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. John Giudicessi]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Peter Noseworthy]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Mayo Clinic]]--></mayoclinic:mctag>	</item>
		<item>
		<title>Mayo Clinic researchers identify a new stem cell patch to gently heal damaged hearts</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-identify-a-new-stem-cell-patch-to-gently-heal-damaged-hearts/
		
		<dc:creator><!--[CDATA[mbroadfoot]]--></dc:creator>
		<pubdate>Wed, 05 Nov 2025 16:17:48 +0000</pubdate>
				<category><!--[CDATA[Arizona]]--></category>
		<category><!--[CDATA[Cardiovascular]]--></category>
		<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[News Releases]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[Transplant]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[Arizona News Releases]]--></category>
		<category><!--[CDATA[daily]]--></category>
		<category><!--[CDATA[Dr. Wugiang Zhu]]--></category>
		<category><!--[CDATA[Stem Cells]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=407550</guid>

					<description><!--[CDATA[<p-->PHOENIX&nbsp;—&nbsp;Mayo Clinic&nbsp;researchers have developed a pioneering method to mend damaged hearts without open-heart surgery, an advance that could one day transform the treatment of heart failure.&nbsp; The new approach uses lab-grown heart tissue made from reprogrammed adult stem cells, delivered through a tiny incision rather than a surgically opened chest cavity. In preclinical testing, the […]<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-identify-a-new-stem-cell-patch-to-gently-heal-damaged-hearts/">Mayo Clinic researchers identify a new stem cell patch to gently heal damaged hearts</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[
<figure class="wp-block-image size-large is-style-center-align-caption"--><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Stem-cell-pipette-GettyImages-1150965935-16-x-9-1024x576.jpg" alt="A researcher uses a pipette to place stem cells into a multiwell plate, with an image of the cells shown beneath." class="wp-image-407637" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Stem-cell-pipette-GettyImages-1150965935-16-x-9-1024x576.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Stem-cell-pipette-GettyImages-1150965935-16-x-9-300x169.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Stem-cell-pipette-GettyImages-1150965935-16-x-9-768x432.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Stem-cell-pipette-GettyImages-1150965935-16-x-9.jpg 1425w" sizes="auto, (max-width: 1024px) 100vw, 1024px"><figcaption class="wp-element-caption">A researcher uses a pipette to place stem cells into a multiwell plate, with an image of the cells shown beneath.</figcaption>



<p>PHOENIX&nbsp;—&nbsp;<a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&nbsp;researchers have developed a pioneering method to mend damaged hearts without open-heart surgery, an advance that could one day transform the treatment of heart failure.&nbsp;</p>



<p>The new approach uses lab-grown heart tissue made from reprogrammed adult stem cells, delivered through a tiny incision rather than a surgically opened chest cavity. In preclinical testing, the stem cell patch restored heart function and improved healing.</p>


<div class="wp-block-image">
<figure class="alignright size-full is-resized"><img loading="lazy" decoding="async" width="855" height="855" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Zhu-Wuqiang_21415234_202406271049-1-x-1.jpg" alt="Wuqiang Zhu, Ph.D." class="wp-image-407638" style="width:154px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Zhu-Wuqiang_21415234_202406271049-1-x-1.jpg 855w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Zhu-Wuqiang_21415234_202406271049-1-x-1-300x300.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Zhu-Wuqiang_21415234_202406271049-1-x-1-150x150.jpg 150w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Zhu-Wuqiang_21415234_202406271049-1-x-1-768x768.jpg 768w" sizes="auto, (max-width: 855px) 100vw, 855px"><figcaption class="wp-element-caption">Wuqiang Zhu, Ph.D.</figcaption></figure></div>


<p>"For patients with severe heart failure, there are very few options beyond mechanical pumps or transplants. We hope this approach will offer a new way to repair their own hearts," says&nbsp;<a href="https://www.mayo.edu/research/faculty/zhu-wuqiang-m-d-ph-d/bio-20465805" target="_blank" rel="noreferrer noopener">Wuqiang Zhu, Ph.D.</a>, senior author of the&nbsp;<a href="https://www.sciencedirect.com/science/article/pii/S174270612500649X?via%3Dihub" target="_blank" rel="noreferrer noopener">study</a>&nbsp;published in Acta Biomaterialia and a cardiovascular researcher at&nbsp;<a href="https://www.mayoclinic.org/patient-visitor-guide/arizona" target="_blank" rel="noreferrer noopener">Mayo Clinic in Arizona</a>.</p>



<h2 class="wp-block-heading"><strong>Reversing the irreversible</strong></h2>



<p><a href="https://www.mayoclinic.org/diseases-conditions/heart-attack/symptoms-causes/syc-20373106" target="_blank" rel="noreferrer noopener">Heart attacks</a> remain one of the leading causes of death worldwide. When blood flow to the heart is blocked, oxygen-starved cells die and are replaced by scar tissue that cannot contract or conduct electrical signals — weakening the heart’s ability to pump blood.</p>



<p>"The adult human heart doesn't regenerate once those cells are lost," Dr. Zhu explains. "That's why heart failure, especially chronic heart failure due to the loss of functional cardiac muscle, is often difficult to treat; the muscle simply can't repair itself."</p>



<p>For years, scientists have been working on ways to replace damaged tissue with healthy heart cells derived from stem cells. Early efforts showed promise, but most required open-heart surgery<a>&nbsp;—&nbsp;</a>a procedure too risky for many patients already struggling with severe&nbsp;<a href="https://www.mayoclinic.org/diseases-conditions/heart-failure/symptoms-causes/syc-20373142" target="_blank" rel="noreferrer noopener">heart failure</a>.</p>



<p>Scientists have long hoped that stem cells could provide a way to rebuild what the body cannot. By reprogramming ordinary adult cells such as skin or blood cells into induced pluripotent stem cells (iPSCs), researchers can coax them into becoming replacement heart cells.</p>



<p>But safely and effectively delivering engineered heart tissues made from these cells has remained a major challenge.</p>



<h2 class="wp-block-heading"><strong>Innovation at heart</strong></h2>



<p>In collaboration with engineers at the University of Nebraska Medical Center, Mayo researchers developed a flexible, paper-thin patch made of nano- and microfibers coated with gelatin. This hybrid scaffold supports a blend of human heart muscle cells, blood vessel cells and fibroblasts—cells that form the tissue’s structural framework—to create a living, beating piece of heart tissue. Before transplantation, the tissue is infused with bioactive factors such as fibroblast growth factor 1 and CHIR99021 that encourage the growth of new blood vessels and help the cells survive once they are in place.</p>



<p>"The beauty of this design," says Dr. Zhu, "is that it can be folded like a piece of paper, loaded into a slender tube, and delivered precisely where it's needed through a small incision in the chest. Once in place, it unfolds and adheres naturally to the heart's surface."</p>



<p>Instead of using stitches, the team used a biocompatible surgical adhesive that holds the patch in place while minimizing additional trauma to the surrounding tissue.</p>



<p>Testing in preclinical models showed that the minimally invasive method improved heart function, reduced scarring, enhanced vascular growth and lessened inflammation compared with conventional approaches.</p>



<p>"Our results show that these engineered tissues not only survive but actually help the heart heal itself," says Dr. Zhu. "That's the ultimate goal: to replace what's lost and restore function."</p>



<h2 class="wp-block-heading"><strong>A step toward regeneration</strong></h2>



<p>The research aligns closely with Mayo Clinic's Genesis Initiative, which aims to accelerate discoveries that restore or regenerate human organs and tissues.</p>



<p>"Genesis is about pioneering new ways to repair and rebuild the human body," Dr. Zhu says. "What we're doing here is exactly that — using regenerative science and minimally invasive delivery to give the heart a chance to recover."</p>



<p>Currently, more than 4,000 <a href="https://www.mayoclinic.org/tests-procedures/heart-transplant/about/pac-20384750" target="_blank" rel="noreferrer noopener">heart transplants</a> are performed in the United States each year, while thousands more patients die waiting for a donor organ. Dr. Zhu hopes this technology could eventually offer another option.</p>



<p>"Our vision," he says, "is that patients could one day receive engineered heart tissue made from their own reprogrammed cells, delivered through a minimally invasive procedure — no donor organ, no long recovery, just a repaired heart."</p>



<h2 class="wp-block-heading"><strong>Next steps</strong></h2>



<p>The Mayo Clinic team plans to advance this work through larger-scale preclinical testing to ensure the therapy's safety and effectiveness before moving to human clinical trials, a process that Dr. Zhu estimates could take five years or more.</p>



<p>"Heart failure remains a devastating condition," he says. "If we can make stem cell treatment accessible to more patients, especially those too fragile for open-heart surgery, we could save lives."</p>



<p>###</p>



<p><strong>About Mayo Clinic</strong><br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the&nbsp;<a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a>&nbsp;for additional Mayo Clinic news.&nbsp;</p>



<p><strong>Media contact:</strong></p>



<ul class="wp-block-list">
<li>Terri Malloy, Mayo Clinic Communications,&nbsp;<a href="mailto:newsbureau@mayo.edu">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-identify-a-new-stem-cell-patch-to-gently-heal-damaged-hearts/">Mayo Clinic researchers identify a new stem cell patch to gently heal damaged hearts</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Stem-cell-pipette-GettyImages-1150965935-1-x-1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Stem-cell-pipette-GettyImages-1150965935-16-x-9.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Arizona News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[daily]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Wugiang Zhu]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Stem Cells]]--></mayoclinic:mctag>	</item>
		<item>
		<title>How Mayo Clinic experts are using AI to better detect sleep apnea, especially in women</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/how-mayo-clinic-experts-are-using-ai-to-better-detect-sleep-apnea-especially-in-women/
		
		<dc:creator><!--[CDATA[Vincent Jacobbi]]--></dc:creator>
		<pubdate>Tue, 04 Nov 2025 13:30:00 +0000</pubdate>
				<category><!--[CDATA[AI and Digital Health]]--></category>
		<category><!--[CDATA[Cardiovascular]]--></category>
		<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[Health & Wellness]]--></category>
		<category><!--[CDATA[Minnesota]]--></category>
		<category><!--[CDATA[News Releases]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[Rochester]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[AI ECG]]--></category>
		<category><!--[CDATA[Dr. Virend Somers]]--></category>
		<category><!--[CDATA[Minnesota News Releases]]--></category>
		<category><!--[CDATA[sleep apnea]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=407501</guid>

					<description><!--[CDATA[<p-->ROCHESTER, Minn. — Mayo Clinic researchers have developed an artificial intelligence (AI) algorithm that can identify obstructive sleep apnea (OSA) using the results from an electrocardiogram (ECG) – a common heart test. The innovation could make it faster, cheaper, and easier to spot sleep apnea, particularly in women, who are often underdiagnosed. A common but […]<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/how-mayo-clinic-experts-are-using-ai-to-better-detect-sleep-apnea-especially-in-women/">How Mayo Clinic experts are using AI to better detect sleep apnea, especially in women</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[<div class="wp-block-image"-->
<figure class="aligncenter size-full"><img loading="lazy" decoding="async" width="800" height="533" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/shutterstock_283528316.jpg" alt="" class="wp-image-407502" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/shutterstock_283528316.jpg 800w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/shutterstock_283528316-300x200.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/shutterstock_283528316-768x512.jpg 768w" sizes="auto, (max-width: 800px) 100vw, 800px"></figure>


<p>ROCHESTER, Minn. — <a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> researchers have developed an artificial intelligence (AI) algorithm that can identify <a href="https://www.mayoclinic.org/diseases-conditions/obstructive-sleep-apnea/symptoms-causes/syc-20352090" target="_blank" rel="noreferrer noopener">obstructive sleep apnea (OSA)</a> using the results from an electrocardiogram (ECG) – a common heart test. The innovation could make it faster, cheaper, and easier to spot sleep apnea, particularly in women, who are often underdiagnosed.</p>



<h2 class="wp-block-heading"><strong>A common but underrecognized condition</strong></h2>



<p>OSA affects more than 936 million adults ages 30-69 worldwide and poses significant cardiovascular risks. People with <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-what-happens-to-your-body-when-you-have-obstructive-sleep-apnea/" target="_blank" rel="noreferrer noopener">OSA</a> experience repeated episodes of upper airway collapse or blockage during sleep. This collapse causes breathing to stop or become shallow repeatedly, which often leads to loud snoring and gasping. Despite its prevalence, it often goes undiagnosed.</p>


<div class="wp-block-image">
<figure class="aligncenter size-full"><img loading="lazy" decoding="async" width="550" height="309" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2019/09/sleep-apnea-16x9-1.jpg" alt="Medical illustration of sleep apnea" class="wp-image-249304" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2019/09/sleep-apnea-16x9-1.jpg 550w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2019/09/sleep-apnea-16x9-1-300x169.jpg 300w" sizes="auto, (max-width: 550px) 100vw, 550px"></figure></div>


<p></p>



<p>"Obstructive sleep apnea or OSA is a highly prevalent disease with important cardiovascular consequences," says <a href="https://www.mayo.edu/research/faculty/somers-virend-m-d-ph-d/bio-00027756" target="_blank" rel="noreferrer noopener">Virend Somers, M.D., Ph.D.</a>, Alice Sheets Marriott Professor of Cardiovascular Medicine and senior author of the <a href="https://pubmed.ncbi.nlm.nih.gov/40961733/" target="_blank" rel="noreferrer noopener">study</a> published in JACC: Advances. "OSA affects the heart to the point where AI algorithms can detect the OSA signature from the ECG, which in essence is a representation of the electrical activity of the heart muscle cells," Dr. Somers adds.</p>



<h2 class="wp-block-heading"><strong>AI model shows strong performance — especially for women</strong></h2>



<p>In the study, the researchers used AI algorithms to review the 12-lead electrocardiogram (ECG) test results of 11,299 patients at Mayo Clinic who had undergone the test along with sleep evaluations. More than 7,000 of them had a known diagnosis of OSA, and 4,000 were controls.</p>



<p>"The most surprising finding was the increased visibility on the ECG of OSA in the females compared to the males, even though the OSA severity was less in the females," says Dr. Somers.</p>



<p>"This is relevant since emerging data consistently suggest that females have a greater relative likelihood of suffering the cardiovascular consequences of OSA, even if their OSA may be considered 'milder' by standard diagnostic criteria," he adds.</p>



<p>The test also strongly suggests women may suffer more damage to their heart muscle cells from OSA, Dr. Somers says.</p>



<p>Dr. Somers underscores that this approach may have the potential to evaluate whether a given OSA treatment may be able to reduce a patient's cardiovascular risk.</p>



<p>Review the <a href="https://pubmed.ncbi.nlm.nih.gov/40961733/" target="_blank" rel="noreferrer noopener">study</a> for a complete list of authors, disclosures and funding.</p>



<p>###</p>



<p><strong>About Mayo Clinic</strong><br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the&nbsp;<a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a>&nbsp;for additional Mayo Clinic news.</p>



<p><strong>Media contact:</strong> </p>



<ul class="wp-block-list">
<li>Terri Malloy, Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/how-mayo-clinic-experts-are-using-ai-to-better-detect-sleep-apnea-especially-in-women/">How Mayo Clinic experts are using AI to better detect sleep apnea, especially in women</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/11/Woman-sleeping-GettyImages-2226499363-1-x-1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/shutterstock_283528316.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[AI ECG]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Virend Somers]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Minnesota News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[sleep apnea]]--></mayoclinic:mctag>	</item>
		<item>
		<title>Mayo Clinic researchers find enhancing the body’s ‘first responder’ cells may boost immune therapy for cancer</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-enhancing-the-bodys-first-responder-cells-may-boost-immune-therapy-for-cancer/
		
		<dc:creator><!--[CDATA[Kate Ledger]]--></dc:creator>
		<pubdate>Wed, 29 Oct 2025 17:14:37 +0000</pubdate>
				<category><!--[CDATA[Cancer]]--></category>
		<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[daily]]--></category>
		<category><!--[CDATA[Dr. Haidong Dong]]--></category>
		<category><!--[CDATA[Dr. Jessica Lancaster]]--></category>
		<category><!--[CDATA[Minnesota News Releases]]--></category>
		<category><!--[CDATA[News Releases]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=407363</guid>

					<description><!--[CDATA[<p-->ROCHESTER, Minn. — Mayo Clinic researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer. Two research teams, working collaboratively but using distinct approaches, found that "first-responder" immune cells known as myeloid cells can be manipulated to enhance the activity of tumor-killing T cells. The […]<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-enhancing-the-bodys-first-responder-cells-may-boost-immune-therapy-for-cancer/">Mayo Clinic researchers find enhancing the body’s ‘first responder’ cells may boost immune therapy for cancer</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[<div class="wp-block-image is-style-left-align-caption"-->
<figure class="aligncenter size-full is-resized"><img loading="lazy" decoding="async" width="562" height="316" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/TcellsANDmacrophages-16-x-9.jpg" alt="A live cell microscopy image of a tumor’s environment shows the interaction of tumor-killing T-cells (magenta) and macrophages (green round cells). They are surrounded by stiff tumor tissue (green fibers) and non-fluorescent tumor cells (black areas). Image captured by Tina Kwok." class="wp-image-407397" style="width:840px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/TcellsANDmacrophages-16-x-9.jpg 562w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/TcellsANDmacrophages-16-x-9-300x169.jpg 300w" sizes="auto, (max-width: 562px) 100vw, 562px"><figcaption class="wp-element-caption">Live cell microscopy image of a tumor’s environment shows the interaction of tumor-killing T-cells (magenta) and macrophages (green round cells),  surrounded by stiff tumor tissue (green fibers) and non-fluorescent tumor cells (black areas). Image captured: Tina Kwok.</figcaption></figure>


<p>ROCHESTER, Minn. — <a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> researchers have identified a specific immune cell that can be targeted to give a boost to standard immunotherapies for cancer. Two research teams, working collaboratively but using distinct approaches, found that "first-responder" immune cells known as myeloid cells can be manipulated to enhance the activity of tumor-killing T cells.</p>



<p>The finding suggests that enhanced myeloid cells may boost certain immune checkpoint therapies, which are the standard of care for some cancers but may not have lasting effects. A clinical trial is now being developed at Mayo Clinic to test the enhanced cells in patients.</p>



<p></p>



<p>In a study in <a href="https://jitc.bmj.com/content/13/10/e012164" target="_blank" rel="noreferrer noopener">Journal for ImmunoTherapy of Cancer</a>, Mayo Clinic researchers detailed how they found a way to boost cancer-killing T cells. The goal was to improve treatments that interfere with immunosuppressive proteins, PD-1 and PD-L1, which together suppress T cells' ability to fight cancer. Even though PD-L1 immunotherapies aim to block PD-L1, the researchers found that the molecule can persist through a natural recycling process that puts it back in play.</p>


<div class="wp-block-image">
<figure class="alignright size-medium is-resized"><img loading="lazy" decoding="async" width="240" height="300" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Dong-Haidong_12985848_20220816-240x300.jpg" alt="Portrait of Dr. Haidong Dong" class="wp-image-407368" style="width:204px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Dong-Haidong_12985848_20220816-240x300.jpg 240w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Dong-Haidong_12985848_20220816.jpg 640w" sizes="auto, (max-width: 240px) 100vw, 240px"><figcaption class="wp-element-caption">Haidong Dong, M.D., Ph.D</figcaption></figure></div>


<p>"Our study found the importance of the recycling process, and we present a way to address it," says <a href="https://www.mayo.edu/research/faculty/dong-haidong-m-d-ph-d/bio-00027557" target="_blank" rel="noreferrer noopener">Haidong Dong, M.D., Ph.D.</a>, a cancer immunology researcher at <a href="https://www.mayoclinic.org/departments-centers/mayo-clinic-cancer-center/cancer-care" target="_blank" rel="noreferrer noopener">Mayo Clinic Comprehensive Cancer Center</a> and principal investigator of the study.</p>



<p>The research team developed an antibody, H1A, which they found can reduce PD-L1 in human myeloid cells and keep it from recycling. The protein PD-L1 is present in abundance on the surface of myeloid cells. When the protein was prevented from recycling on myeloid cells, the cells then boosted the action of cancer-killing T cells.</p>


<div class="wp-block-image">
<figure class="alignleft size-medium is-resized"><img loading="lazy" decoding="async" width="240" height="300" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Hsu-Michelle-A._30026716_202509162045-240x300.jpg" alt="Portrait of Michelle Hsu" class="wp-image-407367" style="width:200px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Hsu-Michelle-A._30026716_202509162045-240x300.jpg 240w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Hsu-Michelle-A._30026716_202509162045.jpg 640w" sizes="auto, (max-width: 240px) 100vw, 240px"><figcaption class="wp-element-caption">Michelle Hsu</figcaption></figure></div>


<p></p>



<p>"We now have a tool that can completely remove PD-L1 and in doing so we have more myeloid cell activation," says lead author of the study, Michelle Hsu, who conducted the research as her graduate thesis at <a href="https://college.mayo.edu/academics/biomedical-research-training/" target="_blank" rel="noreferrer noopener">Mayo Clinic Graduate School of Biomedical Sciences</a>. "Identifying the myeloid cell was an unexpected discovery," she says. </p>


<div class="wp-block-image">
<figure class="alignright size-medium is-resized"><img loading="lazy" decoding="async" width="240" height="300" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Lancaster-Jessica-N._21667098_202502181545-240x300.jpg" alt="Portrait of Dr. Jessica Lancaster" class="wp-image-407369" style="width:186px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Lancaster-Jessica-N._21667098_202502181545-240x300.jpg 240w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Lancaster-Jessica-N._21667098_202502181545.jpg 640w" sizes="auto, (max-width: 240px) 100vw, 240px"><figcaption class="wp-element-caption">Jessica Lancaster, Ph.D.</figcaption></figure></div>


<p>Another Mayo Clinic team took a different approach and arrived at a similar conclusion about the importance of myeloid cells. A research team led by immunology researcher <a href="https://www.mayo.edu/research/faculty/lancaster-jessica-n-ph-d/bio-20482482" target="_blank" rel="noreferrer noopener">Jessica Lancaster, Ph.D.</a>, at <a href="https://www.mayoclinic.org/patient-visitor-guide/arizona" target="_blank" rel="noreferrer noopener">Mayo Clinic in Arizona</a>, reported in <a href="https://www.sciencedirect.com/science/article/pii/S2589004225017997" target="_blank" rel="noreferrer noopener">iScience</a> that macrophages, a type of myeloid cell, play a role in activating the cancer-killing T cells.</p>



<p></p>



<p><strong><a href="https://www.youtube.com/watch?v=-CcIVENx1zI"><br>Watch animation</a></strong></p>



<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<div class="fluidEmbed"><iframe loading="lazy" id="videoidCcIVENx1zI" title="Tcell and macrophage" width="500" height="281" src="https://www.youtube.com/embed/-CcIVENx1zI?feature=oembed&amp;enablejsapi=1" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen=""></iframe></div>
</div></figure>



<p><em><strong>Animation available in the downloads:</strong>  Live cell microscopy shows a cancer-killing T cell (magenta) as it migrates and interacts with macrophages (blue) in the tumor microenvironment. Black spaces are packed with non-fluorescent tumor cells. Image captured by Tina Kwok, Mayo Clinic.</em><br></p>



<p>Using the complex approach of live-cell microscopy, the team found that in mice, T cells interact closely with the macrophages and create a molecular environment that has greater capacity to kill a tumor.</p>



<p>"This is a paradigm shift for PD-L1 immunotherapy, which has traditionally focused on the interaction of the tumor and the T cells," says Dr. Lancaster. "We found that it’s important to co-opt the macrophage, which acts as another immune cell partner."</p>


<div class="wp-block-image">
<figure class="alignleft size-medium is-resized"><img loading="lazy" decoding="async" width="240" height="300" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Kwok-Tina_30026717_202506271753-240x300.jpg" alt="Portrait of Tina Kwok" class="wp-image-407366" style="width:179px;height:auto" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Kwok-Tina_30026717_202506271753-240x300.jpg 240w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/Kwok-Tina_30026717_202506271753.jpg 640w" sizes="auto, (max-width: 240px) 100vw, 240px"><figcaption class="wp-element-caption">Tina Kwok</figcaption></figure></div>


<p><br>Further, says lead author Tina Kwok, who completed the studies during her Ph.D. research at Mayo Clinic, "We can directly reprogram tumor macrophages to be more pro-inflammatory. They can become better T-cell activators and drive better tumor control. Reprogramming of the macrophage may be key to being able to prevent therapy resistance and change outcomes for patients."</p>



<p></p>



<p></p>



<p>Based on the findings from both labs, a phase 1 clinical trial of H1A is being planned. The research could ultimately better address resistance to immunotherapy and expand treatment options for people with cancer.</p>



<p>Review the studies in <a href="https://jitc.bmj.com/content/13/10/e012164" target="_blank" rel="noreferrer noopener">Journal for ImmunoTherapy of Cancer</a> and <a href="https://www.sciencedirect.com/science/article/pii/S2589004225017997" target="_blank" rel="noreferrer noopener">iScience</a> for a complete list of authors, disclosures and funding.</p>



<p>###</p>



<p><strong>About Mayo Clinic Comprehensive Cancer Center <br></strong>Designated as a comprehensive cancer center by the&nbsp;<a href="https://www.cancer.gov/" target="_blank" rel="noreferrer noopener">National Cancer Institute</a>,&nbsp;<a href="https://www.mayoclinic.org/departments-centers/mayo-clinic-cancer-center" target="_blank" rel="noreferrer noopener">Mayo Clinic Comprehensive Cancer Center</a> is defining the cancer center of the future, focused on delivering the world's most exceptional patient-centered cancer care for everyone. At Mayo Clinic Comprehensive Cancer Center, a culture of innovation and collaboration is driving research breakthroughs in cancer detection, prevention and treatment to change lives.</p>



<p><strong>About Mayo Clinic</strong><br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the&nbsp;<a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a>&nbsp;for additional Mayo Clinic news.</p>



<p><strong>Media contact</strong>: </p>



<ul class="wp-block-list">
<li>Julie Ferris-Tillman, Ph.D., Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-researchers-find-enhancing-the-bodys-first-responder-cells-may-boost-immune-therapy-for-cancer/">Mayo Clinic researchers find enhancing the body’s ‘first responder’ cells may boost immune therapy for cancer</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/TcellsANDmacrophages-1-x-1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/TcellsANDmacrophages-16-x-9.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[daily]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Haidong Dong]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Jessica Lancaster]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Minnesota News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[News Releases]]--></mayoclinic:mctag>	</item>
		<item>
		<title>Mayo Clinic study finds majority of midlife women with menopause symptoms do not seek care</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-study-finds-majority-of-midlife-women-with-menopause-symptoms-do-not-seek-care/
		
		<dc:creator><!--[CDATA[Sharon Theimer]]--></dc:creator>
		<pubdate>Wed, 29 Oct 2025 09:00:00 +0000</pubdate>
				<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[Minnesota]]--></category>
		<category><!--[CDATA[News Releases]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[daily]]--></category>
		<category><!--[CDATA[Dr. Ekta Kapoor]]--></category>
		<category><!--[CDATA[Minnesota News Releases]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=407252</guid>

					<description><!--[CDATA[<p-->ROCHESTER, Minn. — A new study from Mayo Clinic underscores the widespread impact of menopause symptoms on midlife women — and raises concern that most are navigating this stage of life without medical care to help manage those challenges. The study, published in Mayo Clinic Proceedings, was based on responses from nearly 5,000 women ages […]<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-study-finds-majority-of-midlife-women-with-menopause-symptoms-do-not-seek-care/">Mayo Clinic study finds majority of midlife women with menopause symptoms do not seek care</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[
<figure class="wp-block-image size-large"--><img loading="lazy" decoding="async" width="1024" height="576" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/16x9-feat-image-Kapoor-study-Proceedings-shutterstock_1428227687-1024x576.jpg" alt="" class="wp-image-407253" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/16x9-feat-image-Kapoor-study-Proceedings-shutterstock_1428227687-1024x576.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/16x9-feat-image-Kapoor-study-Proceedings-shutterstock_1428227687-300x169.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/16x9-feat-image-Kapoor-study-Proceedings-shutterstock_1428227687-768x432.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/16x9-feat-image-Kapoor-study-Proceedings-shutterstock_1428227687-1536x864.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/16x9-feat-image-Kapoor-study-Proceedings-shutterstock_1428227687-2048x1152.jpg 2048w" sizes="auto, (max-width: 1024px) 100vw, 1024px">



<p>ROCHESTER, Minn. — A <a href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.mayoclinicproceedings.org%2Fpb-assets%2FHealth%2520Advance%2Fjournals%2Fjmcp%2FJMCP4762.pdf&amp;data=05%7C02%7CFurst.Justin%40mayo.edu%7C96006f986b5a48bf500c08de08248578%7Ca25fff9c3f634fb29a8ad9bdd0321f9a%7C0%7C0%7C638957150871831386%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&amp;sdata=zaP8jQgwJ12UEaFVekeNDuQSVbmxuVVLvIwDBREoZPw%3D&amp;reserved=0" target="_blank" rel="noreferrer noopener">new study</a> from <a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> underscores the widespread impact of <a href="https://www.mayoclinic.org/diseases-conditions/menopause/symptoms-causes/syc-20353397" target="_blank" rel="noreferrer noopener">menopause</a> symptoms on midlife women — and raises concern that most are navigating this stage of life without medical care to help manage those challenges.</p>



<p>The study, published in <a href="https://www.mayoclinicproceedings.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic Proceedings</a>, was based on responses from nearly 5,000 women ages 45-60 who were surveyed across four Mayo Clinic primary care locations. More than 3 out of 4 respondents experienced menopause symptoms, with many reporting substantial effects on daily life, work productivity and overall well-being.</p>



<p>Despite the availability of safe and effective <a href="https://www.mayoclinic.org/diseases-conditions/menopause/diagnosis-treatment/drc-20353401" target="_blank" rel="noreferrer noopener">treatment options</a>, Mayo Clinic researchers found that menopause symptoms remain underrecognized, undertreated and inadequately addressed in the health care system.</p>



<h2 class="wp-block-heading"><strong>Severe symptoms affect daily life, yet few women seek care or receive treatment</strong></h2>



<p>More than one-third (34%) of women who were surveyed reported moderate to very severe symptoms. <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-managing-sleep-during-menopause/" target="_blank" rel="noreferrer noopener">Sleep</a> disturbances and <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-combating-weight-gain-during-menopause/" target="_blank" rel="noreferrer noopener">weight gain</a> were among the most common issues reported by more than half of participants.</p>



<p>The most striking finding was that more than 80% of the women who responded to the survey did not seek medical care for their menopause symptoms. While many women said they preferred to manage symptoms on their own, others said that they were too busy or unaware that effective treatments exist. Only about 1 in 4 women were receiving any treatment for menopause symptoms at the time of the survey.</p>



<p>"Menopause is universal for women at midlife, the symptoms are common and disruptive, and yet, few women are receiving care that could help them," says lead author <a href="https://www.mayoclinic.org/biographies/kapoor-ekta-m-b-b-s/bio-20090811" target="_blank" rel="noreferrer noopener">Ekta Kapoor, M.B.B.S.</a>, an <a href="https://www.mayoclinic.org/departments-centers/endocrinology/sections/overview/ovc-20392506" target="_blank" rel="noreferrer noopener">endocrinologist</a> and <a href="https://www.mayoclinic.org/departments-centers/menopause-womens-sexual-health/overview/ovc-20487915" target="_blank" rel="noreferrer noopener">menopause specialist</a> at Mayo Clinic in Rochester. "This gap has real consequences for women's health and quality of life, and it's time we address it more proactively."</p>



<p>Without proper treatment, menopause symptoms can negatively affect sleep, mood, <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-minute-does-menopause-cause-brain-fog/" target="_blank" rel="noreferrer noopener">cognition</a>, and <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-study-puts-price-tag-on-cost-of-menopause-symptoms-for-women-in-the-workplace/" target="_blank" rel="noreferrer noopener">productivity</a> at work and at home. The findings underscore the importance of healthcare professionals proactively identifying and managing menopause symptoms in patients who may be struggling with them, the authors said.</p>



<h2 class="wp-block-heading"><strong>Researchers call for proactive care strategies and new tools to close the treatment gap</strong></h2>



<p>The study noted that women often do not voluntarily mention concerns about menopause symptoms to their healthcare professional. Mayo Clinic researchers emphasize the need for strategies that destigmatize menopause care and make it more visible and accessible. Efforts are underway to develop questionnaires, digital tools and smartphone apps that help women identify symptoms, learn about treatment options and have more productive discussions with their primary care professionals.</p>



<p>"Our goal is to educate women and healthcare professionals about menopause," Dr. Kapoor says. "By making it easier to recognize and understand symptoms, we can close the gap between need and care — and help midlife women live healthier, more fulfilling lives."</p>



<p>Review the study for a complete list of authors, disclosures and funding.&nbsp; A <a href="https://www.youtube.com/watch?v=31WDB0JRpVI" target="_blank" rel="noreferrer noopener">video</a> of Dr. Kapoor discussing the findings is available.</p>



<p>###</p>



<p><strong>About Mayo Clinic Proceedings</strong> <br>One of the premier peer-reviewed clinical journals in general and internal medicine, <a href="https://www.mayoclinicproceedings.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic Proceedings</a><em> </em>is among the most widely read and highly cited scientific publications for physicians. Continuously published since 1926 and celebrating its <a href="https://www.elsevier.com/en-in/subject/medicine/mayo-clinic-family-of-journals/mcp-100-years" target="_blank" rel="noreferrer noopener">centennial next year</a>, <em>Mayo Clinic Proceedings</em> is sponsored by Mayo Clinic, guided by its Bold. Forward. vision to transform medicine as the global authority in the care of serious or complex disease. The journal publishes original research, articles and commentary from authors worldwide and has an Impact Factor of 6.7, placing it in the top 10% among general and internal medicine journals.</p>



<p><strong>About Mayo Clinic</strong> <br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the <a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a> for additional Mayo Clinic news.&nbsp;&nbsp;</p>



<p><strong>Media contact</strong>:</p>



<ul class="wp-block-list">
<li>Sharon Theimer, Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a></li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-study-finds-majority-of-midlife-women-with-menopause-symptoms-do-not-seek-care/">Mayo Clinic study finds majority of midlife women with menopause symptoms do not seek care</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/1x1-feat-image-Kapoor-study-Proceedings-shutterstock_1428227687.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/16x9-feat-image-Kapoor-study-Proceedings-shutterstock_1428227687.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[daily]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Dr. Ekta Kapoor]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Minnesota News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[News Releases]]--></mayoclinic:mctag>	</item>
		<item>
		<title>Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some</title>
		<link>https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-discovery-of-breast-cancer-treatment-resistance-can-lead-to-new-hope-for-some/
		
		<dc:creator><!--[CDATA[Vincent Jacobbi]]--></dc:creator>
		<pubdate>Tue, 28 Oct 2025 17:08:27 +0000</pubdate>
				<category><!--[CDATA[Cancer]]--></category>
		<category><!--[CDATA[Featured News]]--></category>
		<category><!--[CDATA[News Releases]]--></category>
		<category><!--[CDATA[Research]]--></category>
		<category><!--[CDATA[Rochester]]--></category>
		<category><!--[CDATA[#Newsapp]]--></category>
		<category><!--[CDATA[Minnesota News Releases]]--></category>
		<guid ispermalink="false">https://newsnetwork.mayoclinic.org/?p=407323</guid>

					<description><!--[CDATA[<p-->ROCHESTER, Minn. —&nbsp;Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets cancer cells with a strong chemotherapy drug. For many patients with human epidermal growth factor receptor 2-positive (HER2+) breast […]<p></p>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-discovery-of-breast-cancer-treatment-resistance-can-lead-to-new-hope-for-some/">Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></description>
										<content:encoded><!--[CDATA[
<figure class="wp-block-image size-large"--><img loading="lazy" decoding="async" width="1024" height="682" src="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/A-breast-cancer-patient-sits-on-the-examination-table-and-shares-her-symptoms-with-her-physician_GettyImages-2148188847-1024x682.jpg" alt="A breast cancer patient sits on the examination table and shares her symptoms with her physician." class="wp-image-407381" srcset="https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/A-breast-cancer-patient-sits-on-the-examination-table-and-shares-her-symptoms-with-her-physician_GettyImages-2148188847-1024x682.jpg 1024w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/A-breast-cancer-patient-sits-on-the-examination-table-and-shares-her-symptoms-with-her-physician_GettyImages-2148188847-300x200.jpg 300w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/A-breast-cancer-patient-sits-on-the-examination-table-and-shares-her-symptoms-with-her-physician_GettyImages-2148188847-768x512.jpg 768w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/A-breast-cancer-patient-sits-on-the-examination-table-and-shares-her-symptoms-with-her-physician_GettyImages-2148188847-1536x1024.jpg 1536w, https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/A-breast-cancer-patient-sits-on-the-examination-table-and-shares-her-symptoms-with-her-physician_GettyImages-2148188847.jpg 1688w" sizes="auto, (max-width: 1024px) 100vw, 1024px">



<p>ROCHESTER, Minn. —&nbsp;<a href="https://www.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic</a> researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets cancer cells with a strong chemotherapy drug. For many patients with human epidermal growth factor receptor 2-positive (<a href="https://www.mayoclinic.org/diseases-conditions/breast-cancer/expert-answers/breast-cancer/faq-20058066" target="_blank" rel="noreferrer noopener">HER2+</a>) breast cancers, ADCs such as <a href="https://www.mayoclinic.org/drugs-supplements/fam-trastuzumab-deruxtecan-nxki-intravenous-route/description/drg-20481655" target="_blank" rel="noreferrer noopener">trastuzumab deruxtecan (T-DXd)</a> have dramatically improved outcomes.</p>



<p>"While T-DXd has shown remarkable results for many patients, it hasn't worked for everyone with advanced HER2+ breast cancer," says <a href="https://www.mayo.edu/research/faculty/lucas-peter-c-m-d-ph-d/bio-20571057" target="_blank" rel="noreferrer noopener">Peter Lucas, M.D., Ph.D.</a>, vice chair for research in the <a href="https://www.mayoclinic.org/departments-centers/laboratory-medicine-pathology/overview" target="_blank" rel="noreferrer noopener">Department of Laboratory Medicine and Pathology</a> at Mayo Clinic and co-senior author of the <a href="https://www.nature.com/articles/s43018-025-00969-4" target="_blank" rel="noreferrer noopener">study</a>, published in Nature Cancer. "This indicates that some tumors have built-in resistant mechanisms that prevent the drug from doing its job."</p>



<p>In the study, researchers in the <a href="https://www.mayo.edu/research/labs/oncoimmune-signaling-therapeutics/overview" target="_blank" rel="noreferrer noopener">Oncoimmune Signaling and Therapeutics Laboratory</a> at Mayo Clinic discovered that a shortened version of the HER2 protein, called p95HER2, that is produced by a subset of HER2+ breast cancers can alter treatment response. The protein p95HER2 "signals differently" from the full HER2 oncoprotein — which proved to be the key to how it drives therapy resistance.</p>



<p>"Our discovery that p95HER2 has the unique ability to induce signals that produce an immune-protected microenvironment strongly suggested that p95HER2 could function within cancer cells to actively resist T-DXd," says Dr. Lucas.</p>



<p>The study also revealed that a drug called <a href="https://www.mayoclinic.org/drugs-supplements/neratinib-oral-route/description/drg-20406380" target="_blank" rel="noreferrer noopener">neratinib</a> is highly effective at blocking the action of p95HER2, even causing the protein to be degraded.</p>



<p>"In fact, treatment with neratinib results in complete p95HER2 degradation, abolishing the protein from the cancer cells in our preclinical models," says Dong Hu, Ph.D., a research scientist in Laboratory Medicine and Pathology at Mayo Clinic and lead author of the manuscript.</p>



<p>Based on these findings, the research team believes the next step is a clinical trial to evaluate the combination of neratinib with T-DXd in patients with HER2+ early breast cancer. The goal is to determine if this combination therapy can improve the response in cancers that co-express p95HER2 along with full HER2.</p>



<p>They note that this is just one of many therapeutic combinations being considered.</p>



<p>"No single, one-size-fits-all approach to treatment will work for every patient with HER2+ breast cancer," says <a href="https://www.mayo.edu/research/faculty/mcallister-linda-m-m-d-ph-d/bio-20568725" target="_blank" rel="noreferrer noopener">Linda McAllister, M.D., Ph.D.</a>, a pediatric hematologist/oncologist at Mayo Clinic and co-senior author of the study.</p>



<p>However, with the discovery of p95HER2's role, a clear roadmap for future treatment is in sight.</p>



<p>"Having this new understanding of why T-DXd does not always work helps us to envision next steps toward customized therapies and more cures," says Dr. Lucas. "It's all about staying one step ahead of cancer."</p>



<p>For a complete list of authors, disclosures and findings, review the <a href="https://www.nature.com/articles/s43018-025-00969-4" target="_blank" rel="noreferrer noopener">study</a>. The work was supported by the <a href="https://www.mayo.edu/research/centers-programs/cancer-research/specialized-programs-research-excellence-spore-grants/breast-cancer/research-projects/p95her2-antitumor-immunity-efficacy-her2-directed-antibody-drug-conjugates" target="_blank" rel="noreferrer noopener">Mayo Clinic Breast Cancer SPORE</a>.</p>



<p>####</p>



<p><strong>About Mayo Clinic Comprehensive Cancer Center </strong><br>Designated as a comprehensive cancer center by the <a href="https://www.cancer.gov/" target="_blank" rel="noreferrer noopener">National Cancer Institute</a>, <a href="https://www.mayoclinic.org/departments-centers/mayo-clinic-cancer-center" target="_blank" rel="noreferrer noopener">Mayo Clinic Comprehensive Cancer Center</a> is defining the cancer center of the future, focused on delivering the world's most exceptional patient-centered cancer care for everyone. At Mayo Clinic Comprehensive Cancer Center, a culture of innovation and collaboration is driving research breakthroughs in cancer detection, prevention and treatment to change lives.</p>



<p><strong>About Mayo Clinic</strong><br><a href="https://www.mayoclinic.org/about-mayo-clinic" target="_blank" rel="noreferrer noopener">Mayo Clinic</a>&nbsp;is a nonprofit organization committed to innovation in clinical practice, education and research, and providing compassion, expertise and answers to everyone who needs healing. Visit the&nbsp;<a href="https://newsnetwork.mayoclinic.org/" target="_blank" rel="noreferrer noopener">Mayo Clinic News Network</a>&nbsp;for additional Mayo Clinic news.</p>



<p><strong>Media contact:</strong>&nbsp;</p>



<ul class="wp-block-list">
<li>Julie Ferris-Tillman, Ph.D., Mayo Clinic Communications, <a href="mailto:newsbureau@mayo.edu" target="_blank" rel="noreferrer noopener">newsbureau@mayo.edu</a>&nbsp;</li>
</ul>
<p>The post <a href="https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-discovery-of-breast-cancer-treatment-resistance-can-lead-to-new-hope-for-some/">Mayo Clinic discovery of breast cancer treatment resistance can lead to new hope for some</a> appeared first on <a href="https://newsnetwork.mayoclinic.org">Mayo Clinic News Network</a>.</p>
]]></content:encoded>
					
		
		
		<mayoclinic:mcimg1x1>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/A-breast-cancer-patient-sits-on-the-examination-table-and-shares-her-symptoms-with-her-physician_GettyImages-2148188847_1x1.jpg</mayoclinic:mcimg1x1>
<mayoclinic:mcimg16x9>https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2025/10/A-breast-cancer-patient-sits-on-the-examination-table-and-shares-her-symptoms-with-her-physician_GettyImages-2148188847_16x9.jpg</mayoclinic:mcimg16x9>
<mayoclinic:mctag><!--[CDATA[#Newsapp]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[Minnesota News Releases]]--></mayoclinic:mctag><mayoclinic:mctag><!--[CDATA[News Releases]]--></mayoclinic:mctag>	</item>
	</atom:link></channel>
</rss> 